DTL
SNDX icon

Dynamic Technology Lab’s Syndax Pharmaceuticals SNDX Stock Holding History

Dynamic Technology Lab’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,913
Closed -$450K – 1508
2022
Q1 		$450K Buy
+25,913
New +$436K 0.05% 624
2017
Q4 		– Sell
-13,108
Closed -$154K – 1312
2017
Q3 		$154K Buy
+13,108
New +$161K 0.03% 940

Other funds holding SNDX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Dynamic Technology Lab's SNDX Position: Q2 2022 in Review

Dynamic Technology Lab sold out of Syndax Pharmaceuticals (SNDX) in Q2 2022, closing a stake of 25,913 shares — an estimated $450K sold.

Dynamic Technology Lab first reported a position in SNDX in Q3 2017 and held it in 2 quarters. The position peaked at $450K in Q1 2022. 121 funds tracked by Wall St. Rank hold SNDX as of Q2 2022.

  • Dynamic Technology Lab reported no remaining Syndax Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,913 Syndax Pharmaceuticals shares in Q2 2022, an estimated $450K.
  • Dynamic Technology Lab first reported a position in Syndax Pharmaceuticals in Q3 2017 and held it in 2 quarters.
  • Dynamic Technology Lab's Syndax Pharmaceuticals position peaked at $450K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2022.

Based on Dynamic Technology Lab's 13F filing for Q2 2022, filed 12 Aug 2022.